Medical News

RSS

Biosimilar medications could cut spending on biologics in the U.S. by $44 billion

Introducing competing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade, according to new analysis from the RAND Corporation.

6 Nov 2014

New correlation found between specific molecular features of CLL and patients with different prognosis

If chronic lymphocytic leukemia patients with a good or poor prognosis could be identified already at the time of diagnosis, physicians would have better possibilities to adjust their therapeutic and follow-up strategies. Now researchers at Uppsala University, together with international colleagues, have discovered a new correlation between specific molecular features of the disease and subgroups of patients with different prognosis.

6 Nov 2014

Researchers explore why many patients opt out of bariatric surgical procedure

Researchers from the University Health Network in Toronto are hoping to improve the operational efficiency of bariatric surgery programs to increase access to care. Studies have shown that bariatric operations can alleviate chronic health issues like diabetes and arthritis for extremely obese people.

6 Nov 2014

Effects of unhealthy lifestyle persist even after atherosclerosis treatment

Almost everyone knows that improving your eating habits will most likely improve your health. What most people may not know, however, is that the effects of poor eating habits persist long after dietary habits are improved. In a new report appearing in the November 2014 issue of the Journal of Leukocyte Biology, scientists use mice to show that even after successful treatment of atherosclerosis (including lowering of blood cholesterol and a change in dietary habits) the effects of an unhealthy lifestyle still affect the way the immune system functions.

6 Nov 2014

Cellular and Molecular Gastroenterology and Hepatology joins AGA's other peer-reviewed journals

The American Gastroenterological Association is pleased to welcome a new member to its family of journals: Cellular and Molecular Gastroenterology and Hepatology (CMGH). CMGH will showcase cutting-edge digestive biology research in a digital open-access format.

6 Nov 2014

Effective treatment for sleep disturbance may lower risk of drug and alcohol relapse recovery

Insomnia is a "prevalent and persistent" problem for patients in the early phases of recovery from the disease of addiction—and may lead to an increased risk of relapse, according to a report in the November/December Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

6 Nov 2014

Penn researchers show that 23% of patients who survive septic shock return to hospital within 30 days

A diagnosis of septic shock was once a near death sentence. At best, survivors suffered a substantially reduced quality of life.

6 Nov 2014

Incidence of colon and rectal cancer expected to increase by 2030 among young patients

In the next 15 years, more than one in 10 colon cancers and nearly one in four rectal cancers will be diagnosed in patients younger than the traditional screening age, according to researchers at The University of Texas MD Anderson Cancer Center.

6 Nov 2014

Asthma patients using behavioral therapy can improve lung health over the long-term

Asthma patients taught to habitually resist the urge to take deep breaths when experiencing symptoms were rewarded with fewer symptoms and healthier lung function, according to a new study from Southern Methodist University, Dallas.

6 Nov 2014

LA BioMed to receive Phase II funding through Grand Challenges Explorations

Los Angeles Biomedical Research Institute announced today that it will receive Phase II funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test bold ideas to address persistent health and development challenges.

6 Nov 2014

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.

5 Nov 2014

Commonly prescribed drugs for arthritis and pain may increase risk of death from stroke

Commonly prescribed, older drugs for arthritis and pain may increase the risk of death from stroke, according to a study published in the November 5, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology. Stroke is the fourth leading cause of death in the United States, according to the Centers for Disease Control and Prevention.

5 Nov 2014

UTSA professor selected to receive NSF grant to study complex brain processes

Fidel Santamaria, associate professor of biology in the UTSA College of Sciences, is one of 36 researchers in the nation selected to receive a two-year $300,00 National Science Foundation (NSF) Early Concept Grant for Exploratory Research (EAGER). The funding supports President Obama's BRAIN Initiative, a federal effort to support researchers to create new technology that will demystify complex brain processes.

5 Nov 2014

UW researchers successfully replicate direct brain-to-brain connection between people

University of Washington researchers have successfully replicated a direct brain-to-brain connection between pairs of people as part of a scientific study following the team's initial demonstration a year ago. In the newly published study, which involved six people, researchers were able to transmit the signals from one person's brain over the Internet and use these signals to control the hand motions of another person within a split second of sending that signal.

5 Nov 2014

Cardio3 BioSciences announces acquisition of CorQuest Medical

Cardio3 BioSciences, a leader in the discovery and development of regenerative, protective and reconstructive therapies, announces today that it has acquired U.S.-based CorQuest Medical Inc. CorQuest Medical specializes in the development of innovative devices and technologies for cardiac surgery.

5 Nov 2014

Hospira launches Paricalcitol Injection

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol Injection, a generic version of AbbVie's Zemplar. Hospira obtained U.S. Food and Drug Administration approval of paricalcitol on Oct. 21 and launched the product Nov. 1.

5 Nov 2014

TriHealth, Select Medical to jointly operate new acute inpatient rehabilitation hospital in Cincinnati

TriHealth and Select Medical today announced they have completed an agreement to jointly operate a new 60-bed, acute inpatient rehabilitation hospital in 2016 in Keystone Park, along Interstate 71 and Dana Avenue.

5 Nov 2014

Gentiva Health Services reports revenues of $498.0 million for Q3 2014

Gentiva Health Services, Inc., one of the largest providers of home health, hospice and community care services in the United States, today reported net revenues of $498.0 million, adjusted EBITDA of $48.5 million and adjusted income attributable to Gentiva shareholders per diluted share of $0.28.

5 Nov 2014

Mortality gap persists for elderly men with severe mental disorders

The excess mortality experienced by men with severe mental disorders, compared with their mentally healthy peers, does not decrease with age, Australian research shows.

5 Nov 2014

Medical illness common in bipolar disorder

Patients with bipolar disorder have high rates of medical illness, which often exceeds the levels observed in patients with unipolar depression, show results of a UK-based study.

5 Nov 2014

Medical News

Biosimilar medications could cut spending on biologics in the U.S. by $44 billion

New correlation found between specific molecular features of CLL and patients with different prognosis

Researchers explore why many patients opt out of bariatric surgical procedure

Effects of unhealthy lifestyle persist even after atherosclerosis treatment

Cellular and Molecular Gastroenterology and Hepatology joins AGA's other peer-reviewed journals

Effective treatment for sleep disturbance may lower risk of drug and alcohol relapse recovery

Penn researchers show that 23% of patients who survive septic shock return to hospital within 30 days

Incidence of colon and rectal cancer expected to increase by 2030 among young patients

Asthma patients using behavioral therapy can improve lung health over the long-term

LA BioMed to receive Phase II funding through Grand Challenges Explorations

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Commonly prescribed drugs for arthritis and pain may increase risk of death from stroke

UTSA professor selected to receive NSF grant to study complex brain processes

UW researchers successfully replicate direct brain-to-brain connection between people

Cardio3 BioSciences announces acquisition of CorQuest Medical

Hospira launches Paricalcitol Injection

TriHealth, Select Medical to jointly operate new acute inpatient rehabilitation hospital in Cincinnati

Gentiva Health Services reports revenues of $498.0 million for Q3 2014

Mortality gap persists for elderly men with severe mental disorders

Medical illness common in bipolar disorder

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News